<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02283866</url>
  </required_header>
  <id_info>
    <org_study_id>CWJung_BA</org_study_id>
    <nct_id>NCT02283866</nct_id>
  </id_info>
  <brief_title>Bispectral Index-Guided Versus Fixed Dose Administration of Desflurane During Balanced Anesthesia With Remifentanil</brief_title>
  <official_title>Bispectral Index-Guided Versus Fixed Dose Administration of Desflurane During Balanced Anesthesia With Remifentanil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      Balanced anesthesia combining volatile anesthetics and opioids is commonly used in modern
      anesthesia. The purpose of this study is to compare two methods of administering desflurane,
      an volatile anesthetic during balanced anesthesia. The investigators hypothesized that
      administering desflurane at 1 MAC (minimum alveolar concentration) during balanced anesthesia
      will be more beneficial in terms of stability of the patient's vital signs and hypnotic depth
      than administering desflurane according to the patient's BIS (bispectral index) value.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The difference of 'wobble' value of the patients' BIS value between the two groups</measure>
    <time_frame>Every second from 10 minutes after skin incision to 10 minutes before surgery end.</time_frame>
    <description>'Wobble' is a variable that can measure the performance measurement of a pharmacokinetic model, or the reaction of the patient to a drug. We can calculate the performance error from the target of the therapy and the actual measured value, and derive the wobble by a specific formulas, which are described below.
PE=(BISmeasured-BIStargeted)x100/BIStargeted MDPEi = median{PEij, j=1,…,Ni} MDAPEi = median{|PEij|, j=1,…,Ni} Wobblei = median{|PEij-MDPEi|, j=1,…,Ni} Divergence = slope{|PEij|, j=1,…,Ni}</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The difference of 'wobble' value of the patients' systolic arterial blood pressure value between the two groups</measure>
    <time_frame>Every 2.5 minutes from 10 minutes after skin incision to 10 minutes before surgery end</time_frame>
    <description>Described above</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Eye opening time to prodding after stopping of anesthetics.</measure>
    <time_frame>1 min,2 min,3 min, 4min, 5min, 6min, 7min, 8min, 9min, 10min after stopping injection of anesthetics</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Stabilizing Hypnotic Depth and Vital Sign During Balanced Anesthesia</condition>
  <arm_group>
    <arm_group_label>Administering desflurane according to the patient's BIS value</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The anesthesiologist administers the volatile anesthetic desflurane to set the patient's BIS value at 50 during balanced anesthesia, and titrate the remifentanil dose to set the patient's systolic arterial blood pressure between 100-140mmHg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Administering desflurane at 1 MAC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The anesthesiologist administers the volatile anesthetic desflurane at 1 MAC during balanced anesthesia, and titrate the remifentanil dose to set the patient's systolic arterial blood pressure between 100-140mmHg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Administering desflurane according to the patient's BIS value</intervention_name>
    <description>Administering desflurane according to the patient's BIS value</description>
    <arm_group_label>Administering desflurane according to the patient's BIS value</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Administering desflurane at 1 MAC</intervention_name>
    <description>Administering desflurane at 1 MAC</description>
    <arm_group_label>Administering desflurane at 1 MAC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for operation under balanced anesthesia using desflurane and
             remifentanil

        Exclusion Criteria:

          -  Refusal of consent

          -  General anesthesia with agents other than desflurane and remifentanil

          -  Patients with allergy to neuromuscular blocker, volatile anesthetics, opioids

          -  History of malignant hyperthermia

          -  Patients taking CNS stimulants

          -  Chronic alcohol abuser

          -  Patients with severe depressed left ventricular function, EF &lt; 30%

          -  Patients with convulsive disorders

          -  ASA class IV, V, VI

          -  Patients with systolic arterial blood pressure lower than 90mmHg before surgery

          -  Patients needing inotropic infusion during surgery

          -  Anesthesia time less than 30 minutes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chul-Woo Jung</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2014</study_first_submitted>
  <study_first_submitted_qc>November 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2014</study_first_posted>
  <last_update_submitted>July 13, 2015</last_update_submitted>
  <last_update_submitted_qc>July 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Chul-Woo Jung</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

